<DOC>
	<DOCNO>NCT01710748</DOCNO>
	<brief_summary>This study prospective , randomize control , single blind , two-arm , multicenter clinical evaluation . Diabetic patient ( n=112 ) de novo coronary artery disease randomize one 2 treatment arm : 1 ) Reservoir-Based Polymer-Free Amphilimus-Eluting Stent 2 ) Polymer-Based Everolimus-Eluting Stent . The purpose study determine whether Polymer-Free Amphilimus-Eluting Stent implantation effective reduce neointimal hyperplasia compare Polymer-Based Everolimus-Eluting Stent diabetic patient , use Optical Coherence Tomography ( OCT ) primary image modality .</brief_summary>
	<brief_title>Reservoir-Based Polymer-Free Amphilimus-Eluting Stent Versus Polymer-Based Everolimus-Eluting Stent Diabetic Patients</brief_title>
	<detailed_description>In patient diabetes mellitus ( DM ) , drug elute stent ( DES ) show associate great neointimal suppression bare-metal stent . However , ongoing debate optimal drug-eluting stent diabetic patient . This study prospective , randomize control , single blind , two-arm , multicenter clinical evaluation . Diabetic patient ( n=112 ) de novo coronary artery disease randomize one 2 treatment arm : 1 ) Reservoir-Based Polymer-Free Amphilimus-Eluting Stent 2 ) Polymer-Based Everolimus-Eluting Stent . The purpose study determine whether Polymer-Free Amphilimus-Eluting Stent implantation effective reduce neointimal hyperplasia compare Polymer-Based Everolimus-Eluting Stent diabetic patient , use Optical Coherence Tomography ( OCT ) primary image modality .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Clinical Subject eligible PCI . Subject symptomatic coronary artery disease ( stable/unstable angina NonST elevation myocardial infarction ) . Subject know DM . Angiographic Presence 1 2 de novo native coronary artery lesion ( maximum 1 lesion per epicardial coronary artery ) , visual estimation stenosis ≥ 50 % . Target lesion length 1225mm , reference diameter 2.53.5mm . Clinical STsegment elevation myocardial infarction &lt; 48h Presence cardiogenic shock preprocedure Contraindications dual antiplatelet therapy 12 month Left Ventricular Ejection Fraction ≤30 % GFR &lt; 30 ml/min/m2 Target vessel treat previously Platelet count &lt; 75000/mm3 &gt; 700000/mm3 Immunosuppressive therapy Has receive wait list transplant Lifethreatening disease life expectancy &lt; 12 month Pregnant breast feeding patient Inability provide inform consent Angiographic TIMI flow ≤ 1 prior guide wire cross There additional lesion within target vessel plan treat within next 12 month Target vessel saphenous vein graft Target vessel leave main , ostial LAD and/or ostial LCX . Prior PCI target lesion ( restenosis ) Lesion cover single stent ( unplanned bailout stenting allow ) Involved side branch ≥2.5mm visual estimation Rotablator , ELCA brachytherapy Severe calcification target lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Percutaneous coronary intervention</keyword>
	<keyword>Drug elute stent</keyword>
	<keyword>Neointimal hyperplasia</keyword>
	<keyword>Diabetes Mellitus</keyword>
</DOC>